Search details
1.
"I feel empowered": women's perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain.
Cult Health Sex
; 23(8): 1066-1078, 2021 08.
Article
in English
| MEDLINE | ID: mdl-32436478
2.
The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims.
Cost Eff Resour Alloc
; 13: 9, 2015.
Article
in English
| MEDLINE | ID: mdl-26019689
3.
Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis.
J Allergy Clin Immunol
; 131(2): 379-86, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23219170
4.
Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection Administration.
Open Forum Infect Dis
; 11(6): ofae282, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38882931
5.
Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study.
Prim Care Respir J
; 21(3): 267-75, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22614920
6.
Patient and Physician Preferences for Regimen Attributes for the Treatment of HIV in the United States and Canada.
J Pers Med
; 12(3)2022 Feb 23.
Article
in English
| MEDLINE | ID: mdl-35330334
7.
Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy.
AIDS
; 36(2): 195-203, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-34652287
8.
Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness study.
J Int AIDS Soc
; 25(9): e26006, 2022 09.
Article
in English
| MEDLINE | ID: mdl-36097674
9.
Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE).
J Int AIDS Soc
; 25(9): e26003, 2022 09.
Article
in English
| MEDLINE | ID: mdl-36094142
10.
Asthma that is not well-controlled is associated with increased healthcare utilization and decreased quality of life.
J Asthma
; 48(2): 126-32, 2011 Mar.
Article
in English
| MEDLINE | ID: mdl-21128880
11.
Retrospective analysis of adherence to HIV treatment and healthcare utilization in a commercially insured population.
J Med Econ
; 24(1): 1204-1211, 2021.
Article
in English
| MEDLINE | ID: mdl-34665994
12.
Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIV.
Patient
; 13(4): 409-422, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32356146
13.
Real-World Experience with Dolutegravir-Based Two-Drug Regimens.
AIDS Res Treat
; 2020: 5923256, 2020.
Article
in English
| MEDLINE | ID: mdl-32724674
14.
Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study.
Infect Dis Ther
; 9(1): 41-52, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-31701370
15.
Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment options.
AIDS
; 34(14): 2051-2059, 2020 11 15.
Article
in English
| MEDLINE | ID: mdl-33055569
16.
Comparison of corticosteroid nasal sprays in relation to concomitant use and cost of other prescription medications to treat allergic rhinitis symptoms: retrospective cohort analysis of pharmacy claims data.
Clin Drug Investig
; 29(8): 515-26, 2009.
Article
in English
| MEDLINE | ID: mdl-19591513
17.
Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and women.
HIV Clin Trials
; 8(6): 371-80, 2007.
Article
in English
| MEDLINE | ID: mdl-18042502
18.
Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study.
Clin Ther
; 28(5): 745-54, 2006 May.
Article
in English
| MEDLINE | ID: mdl-16861096
19.
Prospective Validation of the Lupus Impact Tracker: A Patient-Completed Tool for Clinical Practice to Evaluate the Impact of Systemic Lupus Erythematosus.
Arthritis Rheumatol
; 68(6): 1422-31, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26814452
20.
SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients.
AIDS
; 18(11): 1529-37, 2004 Jul 23.
Article
in English
| MEDLINE | ID: mdl-15238771